Stock Research for MRK

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

MRK Stock Chart & Research Data

The MRK chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the MRK chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


MRK Due diligence Resources & Stock Charts

The MRK stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View MRK Detailed Price Forecast - CNN Money CNN View MRK Detailed Summary - Google Finance
Yahoo View MRK Detailed Summary - Yahoo! Finance Zacks View MRK Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View MRK Trends & Analysis - Trade-Ideas Barrons View MRK Major Holders - Barrons
NASDAQ View MRK Call Transcripts - NASDAQ Seeking View MRK Breaking News & Analysis - Seeking Alpha
Spotlight View MRK Annual Report - CompanySpotlight.com OTC Report View MRK OTC Short Report - OTCShortReport.com
TradeKing View MRK Fundamentals - TradeKing Charts View MRK SEC Filings - Bar Chart
WSJ View Historical Prices for MRK - The WSJ Morningstar View Performance/Total Return for MRK - Morningstar
MarketWatch View the Analyst Estimates for MRK - MarketWatch CNBC View the Earnings History for MRK - CNBC
StockMarketWatch View the MRK Earnings - StockMarketWatch MacroAxis View MRK Buy or Sell Recommendations - MacroAxis
Bullish View the MRK Bullish Patterns - American Bulls Short Pains View MRK Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View MRK Stock Mentions - StockTwits PennyStocks View MRK Stock Mentions - PennyStockTweets
Twitter View MRK Stock Mentions - Twitter Invest Hub View MRK Investment Forum News - Investor Hub
Yahoo View MRK Stock Mentions - Yahoo! Message Board Seeking Alpha View MRK Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for MRK - SECform4.com Insider Cow View Insider Transactions for MRK - Insider Cow
CNBC View MRK Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for MRK - OTC Markets
Yahoo View Insider Transactions for MRK - Yahoo! Finance NASDAQ View Institutional Holdings for MRK - NASDAQ


Stock Charts

FinViz View MRK Stock Insight & Charts - FinViz.com StockCharts View MRK Investment Charts - StockCharts.com
BarChart View MRK Stock Overview & Charts - BarChart Trading View View MRK User Generated Charts - Trading View




Latest Financial News for MRK


Merck (MRK) Outpaces Stock Market Gains: What You Should Know
Posted on Monday December 10, 2018

In the latest trading session, Merck (MRK) closed at $77.42, marking a +0.91% move from the previous day.


Merck’s President of Global Human Health Adam H. Schechter to Leave Merck Frank Clyburn Named Chief Commercial Officer and Michael Nally Named Chief Marketing Officer
Posted on Monday December 10, 2018

Merck (MRK), known as MSD outside the United States and Canada, today announced that Adam H. Schechter, president of Global Human Health (GHH), is stepping down from his current position as of Dec. 31, 2018, and will be shifting to an advisory capacity to the CEO. The company is taking the opportunity to reshape its commercial organization and is creating two new Executive Committee roles. Frank Clyburn has been promoted to Chief Commercial Officer and Michael Nally has been promoted to Chief Marketing Officer.


Roche's Tecentriq Gets FDA Approval for First-Line NSCLC
Posted on Monday December 10, 2018

Roche's (RHHBY) Tecentriq in combination with Avastin obtains FDA nod for the initial treatment of NSCLC.


PFE Stock Has Broken Its Slump and Could Challenge Former Highs
Posted on Monday December 10, 2018

Pfizer (NYSE:PFE) may find itself doing something it has not done in years—break records. The New York-based pharmaceutical giant found itself stuck as PFE stock spent years mired in a trading range. Now it looks poised to reach and surpass the highs that have eluded Pfizer for almost two decades.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.